|

Gecacitinib Hydrochloride Tablets Clinical Trials

2 actively recruiting trials

Also known as: Gecacitinib

Pipeline

Phase 1/2: 2

Top Sponsors

  • Suzhou Zelgen Biopharmaceuticals Co.,Ltd2

Indications

  • Cancer2
  • Lymphoma1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1

Other2 trials

Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer
Phase 1/2
Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.